REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/16/2025
Back to search
Official data from USPTO
COLD-FIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
06/17/2025
Trademark type
Combined
Nice classes
5
Filing date
03/30/2017
Registration date
06/16/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2020
Last transaction
06/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
LU
Examiner
EVANKO, PATTY
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the following: the stylized wording "COLD-FIX", with a penguin design forming the letter "O" and a check mark forming part of the letter "X" with the word "COLD", the hyphen and the check mark in dark blue and blue, and the letters "FI" and part of the "X" in orange. The color white represents transparent areas and is not a feature of the mark.
Holders and representatives
Holders
M. S. (pessoa física)
M. S. (pessoa física)
Representatives
ALEXANDER LAZOUSKI LAZOUSKI IP LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Sanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseasesrespiratory and infectious diseasesimmunologicalbacterialviral and fungal infectionsherpes infectionsincluding herpes type I and IIgenital herpeslabial herpes and other diseases caused by herpes virusesvaricella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirusrotaviruscoronavirusadenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis viruscalicivirusrespiratory viruses; antibody-based pharmaceutical preparations for the treatment of infection diseases; antibody-based pharmaceutical preparationspharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseasesrespiratory and infectious diseasesimmunologicalbacterialviral and fungal infectionsherpes infectionsincluding herpes type I and IIgenital herpeslabial herpes and other diseases caused by herpes viruses (varicellainfectious mononucleosis); antibody-based pharmaceutical preparations for the prevention and treatment of enterovirusrotaviruscoronavirusesadenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis viruscalicivirusespiratory viruses; pharmaceutical preparations for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposesincluding disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infection diseases
Publications
History of USPTO decisions and trademark events.
40 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/01/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/14/2020
FIMP
FINAL DISPOSITION PROCESSED
10/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/16/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2020
TMBN
TTAB RELEASE CASE TO TRADEMARKS
05/08/2020
OP.T
OPPOSITION TERMINATED NO. 999999
05/08/2020
OP.D
OPPOSITION DISMISSED NO. 999999
05/08/2020
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
04/22/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/02/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/13/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/13/2019
RFNT
REFUSAL PROCESSED BY IB
06/08/2018
OP.I
OPPOSITION INSTITUTED NO. 999999
05/17/2018
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
05/16/2018
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
05/16/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/04/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
02/13/2018
GPNX
NOTIFICATION PROCESSED BY IB
02/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2018
PUBO
PUBLISHED FOR OPPOSITION
01/16/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/27/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/18/2017
RFNT
REFUSAL PROCESSED BY IB
10/14/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2017
RFRR
REFUSAL PROCESSED BY MPU
09/25/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/20/2017
CNRT
NON-FINAL ACTION WRITTEN
09/19/2017
MAFR
APPLICATION FILING RECEIPT MAILED
09/19/2017
DOCK
ASSIGNED TO EXAMINER
09/13/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/07/2017
Continuous trademark protection
Get notified about every new filing that threatens COLD-FIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.